Federated Kaufman Funds

Federated Hermes Kaufmann Funds is a prominent suite of growth-oriented mutual funds managed by Federated Hermes. The funds are well-known for their significant exposure to the healthcare and biotechnology sectors, often participating in initial public offerings (IPOs) and secondary offerings of emerging life science companies. The investment team employs a bottom-up stock selection strategy focusing on companies with strong sales and earnings growth potential regardless of macroeconomic conditions. As of recent filings, the funds hold substantial positions in various biotech and medical technology firms, making them a key institutional stakeholder in the industry. The Kaufmann team is primarily based in New York and manages several billion dollars in assets across small, mid, and large-cap growth strategies.